Our facility, located at 14282 Franklin Avenue, has been designed specifically for the manufacture of monoclonal antibodies and therapeutic proteins derived from mammalian cell culture using stirred tank bioreactor systems. These bioreactors can be operated in batch, fed-batch or perfusion mode, thus providing customers maximum manufacturing flexibility within this system.
The staff assembled by Avid Bioservices® has significant industrial experience in biological Process Development, Manufacturing and Quality System requirements for the manufacture of monoclonal antibodies and recombinant proteins. Call or visit our facility and discuss your particular product issues with our staff.
Facilities manufacturing multi-products for therapeutic applications must demonstrate appropriate controls to maintain component segregation. Close contact with a number of key professionals has led to a design that provides customers with the confidence that their products are being manufactured to cGMP standards. The facility design minimizes changeover and downtime, which facilitates product scheduling and provides customers with economic long-term manufacturing. The flexible design of this facility also provides the opportunity for customers to utilize alternative manufacturing technologies in a cGMP environment.
The contract manufacture of biopharmaceutical products is Avid Bioservices only business. In order to ensure continued availability of cGMP manufacturing capacity, both for new customers and customers with expanding markets, expansion plans have already been drafted for additional dedicated manufacturing suites.
|
